Dang SS, Li YP. Advances in understanding the role of transforming growth factor-β1 in the pathogenesis of liver fibrosis.
Shijie Huaren Xiaohua Zazhi 2010;
18:1631-1636. [DOI:
10.11569/wcjd.v18.i16.1631]
[Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Transforming growth factor-β1 (TGF-β1) is one of the most important cytokines leading to liver fibrosis and is most closely to the development and progression of liver fibrosis and extracellular matrix (ECM) metabolism. Numerous studies have demonstrated that TGF-β1 plays a significant role in the occurrence, development and progression of live fibrosis. Many therapeutic approaches targeting TGF-β1, especially gene therapy and immunotherapy, have been proposed to treat hepatic fibrosis in recent years. Here, we will review the recent advances in understanding the role of TGF-β1 in the pathogenesis of liver fibrosis.
Collapse